Schall, Brown & Schwartz LLP issued a reminder to investors about an ongoing class action against Capricor Therapeutics (NASDAQ: CAPR) alleging violations of §§10(b) and 20(a). The update is largely procedural, but it may keep investor risk concerns elevated around the company’s disclosures and securities practices.
Schall, Brown & Schwartz LLP issued a reminder to investors about an ongoing class action against Capricor Therapeutics (NASDAQ: CAPR) alleging violations of §§10(b) and 20(a). The update is largely procedural, but it may keep investor risk concerns elevated around the company’s disclosures and securities practices.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
